2022 循证共识建议:高复发风险的原发性黑色素瘤患者的随访

2022-03-28 国外肿瘤科相关专家小组(统称) Clin Transl Oncol

尽管早期黑色素瘤患者的预后良好,然仍有相当一部分患者会出现局部或远处复发。本文是由多学科专家小组制定,主要针对复发风险高的原发性黑色素瘤患者的随访提供共识建议。

中文标题:

2022 循证共识建议:高复发风险的原发性黑色素瘤患者的随访

英文标题:

Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus

发布日期:

2022-03-28

简要介绍:

尽管早期黑色素瘤患者的预后良好,然仍有相当一部分患者会出现局部或远处复发。本文是由多学科专家小组制定,主要针对复发风险高的原发性黑色素瘤患者的随访提供共识建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 循证共识建议:高复发风险的原发性黑色素瘤患者的随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f8d071c0023991c8, title=2022 循证共识建议:高复发风险的原发性黑色素瘤患者的随访, enTitle=Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus, guiderFrom=Clin Transl Oncol, authorId=0, author=, summary=尽管早期黑色素瘤患者的预后良好,然仍有相当一部分患者会出现局部或远处复发。本文是由多学科专家小组制定,主要针对复发风险高的原发性黑色素瘤患者的随访提供共识建议。, cover=https://img.medsci.cn/2022330/1648630421395_5579292.png, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Mar 28 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">尽管早期黑色素瘤患者的预后良好,然仍有相当一部分患者会出现局部或远处复发。本文是由多学科专家小组制定,主要针对复发风险高的原发性黑色素瘤患者的随访提供共识建议。</span></p>, tagList=[TagDto(tagId=27275, tagName=恶性黑色素瘤), TagDto(tagId=125143, tagName=原发性黑色素瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4587, appHits=99, showAppHits=0, pcHits=321, showPcHits=4488, likes=1, shares=26, comments=3, approvalStatus=1, publishedTime=Thu Mar 31 15:50:00 CST 2022, publishedTimeString=2022-03-28, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Mar 30 16:54:32 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Wed Jan 03 03:16:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 循证共识建议:高复发风险的原发性黑色素瘤患者的随访.pdf)])
2022 循证共识建议:高复发风险的原发性黑色素瘤患者的随访.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207717, encodeId=c976120e71738, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/9d405764f4c4429ba1357a5460406b02/a3e04204597e4aca8614a200e9b58e40.jpg, createdBy=cbd85312592, createdName=云云众生, createdTime=Fri Apr 01 01:13:49 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207573, encodeId=728a120e573db, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Thu Mar 31 16:15:17 CST 2022, time=2022-03-31, status=1, ipAttribution=)]
    2022-04-01 云云众生

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207717, encodeId=c976120e71738, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/9d405764f4c4429ba1357a5460406b02/a3e04204597e4aca8614a200e9b58e40.jpg, createdBy=cbd85312592, createdName=云云众生, createdTime=Fri Apr 01 01:13:49 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207573, encodeId=728a120e573db, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Thu Mar 31 16:15:17 CST 2022, time=2022-03-31, status=1, ipAttribution=)]
    2022-03-31 POssible

    学习

    0